Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs
Ryan Allway November 24th, 2021 Psychedelics Shipment of GMP DMT, In Vitro HERG and Genotox Assays Completed, and In Vivo Toxicity Assays Underway Vancouver, British Columbia–(November 24, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )